Zhejiang Medicine Co Ltd Capital Reinvestment Ratio
Zhejiang Medicine Co Ltd capital reinvestment ratio. Zhejiang Medicine Co Ltd (600216) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥690.77 Million) in capital expenditures (CN¥80.03 Million). Check Zhejiang Medicine Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhejiang Medicine Co Ltd (1998–2025)
Capital reinvestment ratio of Zhejiang Medicine Co Ltd from 1998 to 2025. This chart tracks Zhejiang Medicine Co Ltd's Capital Reinvestment Ratio across 27 annual periods. Also explore Zhejiang Medicine Co Ltd (600216) net asset momentum to track the company's year-over-year net asset growth rate.
Zhejiang Medicine Co Ltd Capital Reinvestment Ratio by Year (1998–2025)
Zhejiang Medicine Co Ltd capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Medicine Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | CN¥1.89 Billion | CN¥446.47 Million | ▼ -58.0% |
| 2024 | 0.56x | CN¥1.22 Billion | CN¥689.14 Million | ▼ -55.2% |
| 2023 | 1.26x | CN¥634.31 Million | CN¥796.87 Million | ▼ -33.0% |
| 2022 | 1.87x | CN¥520.60 Million | CN¥975.99 Million | ▲ +126.8% |
| 2021 | 0.83x | CN¥1.14 Billion | CN¥939.60 Million | ▲ +94.1% |
| 2020 | 0.43x | CN¥1.26 Billion | CN¥535.35 Million | ▼ -66.8% |
| 2019 | 1.28x | CN¥447.25 Million | CN¥573.63 Million | ▲ +69.3% |
| 2018 | 0.76x | CN¥579.91 Million | CN¥439.30 Million | ▼ -33.1% |
| 2017 | 1.13x | CN¥503.47 Million | CN¥569.99 Million | ▼ -0.3% |
| 2016 | 1.14x | CN¥336.14 Million | CN¥381.76 Million | ▼ -83.3% |
| 2015 | 6.80x | CN¥106.54 Million | CN¥724.96 Million | ▲ +277.3% |
| 2014 | 1.80x | CN¥549.90 Million | CN¥991.76 Million | ▼ -0.5% |
| 2013 | 1.81x | CN¥655.09 Million | CN¥1.19 Billion | ▲ +54.8% |
| 2012 | 1.17x | CN¥807.49 Million | CN¥945.50 Million | ▲ +210.2% |
| 2011 | 0.38x | CN¥912.75 Million | CN¥344.58 Million | ▲ +240.6% |
| 2010 | 0.11x | CN¥1.32 Billion | CN¥145.90 Million | ▲ +6.0% |
| 2009 | 0.10x | CN¥1.47 Billion | CN¥153.13 Million | ▼ -3.7% |
| 2008 | 0.11x | CN¥1.20 Billion | CN¥130.27 Million | ▼ -83.9% |
| 2007 | 0.67x | CN¥227.67 Million | CN¥153.37 Million | ▼ -54.3% |
| 2006 | 1.47x | CN¥169.51 Million | CN¥249.99 Million | ▼ -89.2% |
| 2005 | 13.60x | CN¥25.14 Million | CN¥341.93 Million | ▲ +910.5% |
| 2004 | 1.35x | CN¥107.60 Million | CN¥144.80 Million | ▼ -32.2% |
| 2003 | 1.98x | CN¥66.20 Million | CN¥131.37 Million | ▼ -78.5% |
| 2002 | 9.25x | CN¥23.13 Million | CN¥213.81 Million | ▲ +654.2% |
| 2001 | 1.23x | CN¥98.25 Million | CN¥120.44 Million | ▼ -89.5% |
| 2000 | 11.69x | CN¥10.58 Million | CN¥123.69 Million | ▲ +435.0% |
| 1998 | 2.18x | CN¥57.72 Million | CN¥126.08 Million | — |